BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27311759)

  • 1. Postprandial control of fatty acid transport proteins' subcellular location is not dependent on insulin.
    Snook LA; Wright DC; Holloway GP
    FEBS Lett; 2016 Aug; 590(16):2661-70. PubMed ID: 27311759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid transport proteins chronically relocate to the transverse-tubules in muscle from obese Zucker rats but are resistant to further insulin-induced translocation.
    Stefanyk LE; Bonen A; Dyck DJ
    Metabolism; 2013 Sep; 62(9):1296-304. PubMed ID: 23743348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid transport and transporters in muscle are critically regulated by Akt2.
    Jain SS; Luiken JJ; Snook LA; Han XX; Holloway GP; Glatz JF; Bonen A
    FEBS Lett; 2015 Sep; 589(19 Pt B):2769-75. PubMed ID: 26296318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency.
    Luiken JJ; Arumugam Y; Bell RC; Calles-Escandon J; Tandon NN; Glatz JF; Bonen A
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E612-21. PubMed ID: 12169456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart.
    Chabowski A; Górski J; Calles-Escandon J; Tandon NN; Bonen A
    FEBS Lett; 2006 Jun; 580(15):3617-23. PubMed ID: 16753149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats.
    Bonen A; Jain SS; Snook LA; Han XX; Yoshida Y; Buddo KH; Lally JS; Pask ED; Paglialunga S; Beaudoin MS; Glatz JF; Luiken JJ; Harasim E; Wright DC; Chabowski A; Holloway GP
    Diabetologia; 2015 Oct; 58(10):2381-91. PubMed ID: 26197708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid transport across the cell membrane: regulation by fatty acid transporters.
    Schwenk RW; Holloway GP; Luiken JJ; Bonen A; Glatz JF
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):149-54. PubMed ID: 20206486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic signals controlling glucose transport in skeletal muscle.
    Klip A; Marette A
    J Cell Biochem; 1992 Jan; 48(1):51-60. PubMed ID: 1583073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
    Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
    Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR.
    Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    FEBS Lett; 2005 Apr; 579(11):2428-32. PubMed ID: 15848183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.
    Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E781-9. PubMed ID: 15166001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclists.
    Pelsers MM; Tsintzas K; Boon H; Jewell K; Norton L; Luiken JJ; Glatz JF; van Loon LJ
    Acta Physiol (Oxf); 2007 Jul; 190(3):209-19. PubMed ID: 17394567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6.
    Jain SS; Chabowski A; Snook LA; Schwenk RW; Glatz JF; Luiken JJ; Bonen A
    FEBS Lett; 2009 Jul; 583(13):2294-300. PubMed ID: 19527715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An involvement of the mitochondrial fatty acid transporters in the development of myocellular insulin resistance].
    Lukaszuk B; Chabowski A
    Postepy Hig Med Dosw (Online); 2010 Feb; 64():31-7. PubMed ID: 20173218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes.
    Bonen A; Benton CR; Campbell SE; Chabowski A; Clarke DC; Han XX; Glatz JF; Luiken JJ
    Acta Physiol Scand; 2003 Aug; 178(4):347-56. PubMed ID: 12864739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FATP4 contributes as an enzyme to the basal and insulin-mediated fatty acid uptake of C₂C₁₂ muscle cells.
    Digel M; Staffer S; Ehehalt F; Stremmel W; Ehehalt R; Füllekrug J
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E785-96. PubMed ID: 21750264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between expression of FABPpm in skeletal muscle and insulin sensitivity in intramyocellular lipid-accumulated nonobese men.
    Kawaguchi M; Tamura Y; Kakehi S; Takeno K; Sakurai Y; Watanabe T; Funayama T; Sato F; Ikeda S; Ogura Y; Saga N; Naito H; Fujitani Y; Kanazawa A; Kawamori R; Watada H
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3343-52. PubMed ID: 24937540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane.
    Luiken JJ; Dyck DJ; Han XX; Tandon NN; Arumugam Y; Glatz JF; Bonen A
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E491-5. PubMed ID: 11788383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.